NCT02761642 2018-08-24A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing ChemotherapyHoffmann-La RochePhase 2 Completed200 enrolled 13 charts
NCT02767765 2017-04-04A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With ChemotherapyHoffmann-La RochePhase 3 Completed61 enrolled 11 charts